乙型流感病毒Virus Florida 07/04/Influenza-B Florida_详细资料

产品信息 乙型流感病毒Virus Florida 07/04/Influenza-B Florida 产品编号：IHA-026 产品规格：10μg/50μg/1mg Catalogue Number IHA-026 Introduction Influenza-B virus is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus A as both mutate by both genetic drift and reassortment. Influenza-B virus evolves slower than A viruses and faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, and a polymerasecomplex. Influenza B is sometimes spherical and sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin and neuraminidase. The Influenza B virus is 14648 nucleotideslong and consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, and the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Florida/07/04. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal and beta propiolactone treatment This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/Florida/07/04 solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal. Stability B/Florida/07/04 although stable 4°C for 4 weeks, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles. Immunological Activity Tested with anti-influenza B monoclonal antibodies in ELISA.Serological studies of influenza B virus, immunogen for antibody production. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

您可能感兴趣的产品

乙型流感病毒Virus Florida 07/04/Influenza-B Florida

产品信息

联系我们

关注我们

Catalogue Number	IHA-026
Introduction	Influenza-B virus is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus A as both mutate by both genetic drift and reassortment. Influenza-B virus evolves slower than A viruses and faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, and a polymerasecomplex. Influenza B is sometimes spherical and sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin and neuraminidase. The Influenza B virus is 14648 nucleotideslong and consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, and the nucleocapsids are surrounded by one envelope.
Description	Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Florida/07/04. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.
Inactivation	Thimerosal and beta propiolactone treatment This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Physical Appearance	Sterile Filtered colorless solution.
Formulation	The B/Florida/07/04 solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.
Stability	B/Florida/07/04 although stable 4°C for 4 weeks, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles.
Immunological Activity	Tested with anti-influenza B monoclonal antibodies in ELISA.Serological studies of influenza B virus, immunogen for antibody production.
Purity	Greater than 90.0% as determined by SDS-PAGE.
Usage	ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.